|
Federal
Register Notices > Notices of
Registration - 2006
>
Cambrex North Brunswick, Inc.
FR Doc E6-21878 [Federal Register: December 22, 2006 (Volume 71, Number 246)]
[Notices] [Page 77063-77064] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22de06-104]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated August 15, 2006, and published in the Federal Register on
August 22, 2006, (71 FR 48945-48946), Cambrex North Brunswick, Inc., Technology
Centre of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made
application by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic classes of controlled substances
listed in schedule I and II:
|
Drug
|
Schedule
|
|
N-Ethylamphetamine (1475)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Phenylacetone (8501)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone Intermediate (9254)
|
II
|
|
Morphine (9300)
|
II
|
|
Sufentanil (9740)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
distribution to its customers.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Cambrex North
Brunswick, Inc. to manufacture the listed basic classes of controlled substances
is consistent with the public interest at this time. DEA has investigated
Cambrex North Brunswick, Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included inspection
and testing of the company's physical security systems, verification
[[Page 77064]]
of the company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21
U.S.C. 823, and in
accordance with 21 CFR
1301.33, the above named company is granted registration
as a bulk manufacturer of the basic classes of controlled substances listed.
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-21878 Filed 12-21-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
